Raymond James & Associates Moderna, Inc. Transaction History

Raymond James & Associates

$146 Billion
Q1 2024

A detailed history of Raymond James & Associates transactions in Moderna, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 159,044 shares of MRNA stock, worth $18.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

159,044

Previous 154,442 2.98%

Holding current value

$18.4 Million

Previous $15.4 Million 10.34%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	BUY	$85.37 - $115.44 $392,872 - $531,254	4,602 Added 2.98%	159,044 $16.9 Million
Q4 2023 Jan 16, 2024	SELL	$69.51 - $104.43 $2.22 Million - $3.33 Million	-31,900 Reduced 17.12%	154,442 $15.4 Million
Q3 2023 Oct 24, 2023	BUY	$96.41 - $126.61 $3.03 Million - $3.98 Million	31,423 Added 20.28%	186,342 $19.2 Million
Q2 2023 Jul 25, 2023	BUY	$118.5 - $160.53 $896,097 - $1.21 Million	7,562 Added 5.13%	154,919 $18.8 Million
Q1 2023 Apr 14, 2023	SELL	$135.66 - $197.02 $2.87 Million - $4.16 Million	-21,134 Reduced 12.54%	147,357 $22.6 Million

Q4 2022 Feb 08, 2023	BUY	$118.38 - $210.04 $1.38 Million - $2.45 Million	11,663 Added 7.44%	168,491 $30.3 Million
Q3 2022 Oct 25, 2022	SELL	$118.07 - $194.18 $6.65 Million - $10.9 Million	-56,302 Reduced 26.42%	156,828 $18.5 Million
Q2 2022 Aug 12, 2022	BUY	$117.13 - $176.59 $2.24 Million - $3.38 Million	19,144 Added 9.87%	213,130 $30.4 Million
Q1 2022 May 11, 2022	BUY	$126.46 - $235.05 $2.67 Million - $4.97 Million	21,143 Added 12.23%	193,986 $33.4 Million
Q4 2021 Feb 08, 2022	BUY	$225.82 - $368.51 $5.56 Million - $9.07 Million	24,622 Added 16.61%	172,843 $43.9 Million
Q3 2021 Nov 02, 2021	BUY	$221.9 - $484.47 $245,199 - $535,339	1,105 Added 0.75%	148,221 $57 Million
Q2 2021 Aug 11, 2021	BUY	$129.91 - $234.98 $918,333 - $1.66 Million	7,069 Added 5.05%	147,116 $34.6 Million
Q1 2021 May 14, 2021	BUY	$109.18 - $185.98 $5.39 Million - $9.18 Million	49,381 Added 54.46%	140,047 $18.3 Million
Q4 2020 Feb 12, 2021	BUY	$65.74 - $169.86 $1.11 Million - $2.88 Million	16,940 Added 22.98%	90,666 $9.47 Million
Q3 2020 Nov 04, 2020	SELL	$54.34 - $94.85 $2.21 Million - $3.86 Million	-40,660 Reduced 35.55%	73,726 $5.22 Million
Q2 2020 Jul 28, 2020	BUY	$29.67 - $80.0 $2.54 Million - $6.85 Million	85,597 Added 297.33%	114,386 $7.35 Million
Q1 2020 Apr 21, 2020	BUY	$17.78 - $31.58 $315,079 - $559,629	17,721 Added 160.11%	28,789 $862,000
Q4 2019 Feb 12, 2020	SELL	$13.93 - $21.28 $30,283 - $46,262	-2,174 Reduced 16.42%	11,068 $216,000
Q3 2019 Nov 07, 2019	BUY	$12.26 - $18.07 $18,426 - $27,159	1,503 Added 12.8%	13,242 $211,000
Q2 2019 Aug 06, 2019	SELL	$13.7 - $28.34 $44,264 - $91,566	-3,231 Reduced 21.58%	11,739 $172,000
Q1 2019 May 06, 2019	BUY	$14.45 - $23.7 $216,316 - $354,789	14,970 New	14,970 $305,000

Others Institutions Holding MRNA

# of Institutions

1,038

Shares Held

245M

Call Options Held

12.1M

Put Options Held

9.36M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $45.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Moderna, Inc. Transaction History